Literature DB >> 16083952

Behavioral characterization of morphine effects on motor activity in mice.

Camilla L Patti1, Roberto Frussa-Filho, Regina H Silva, Rita C Carvalho, Sonia R Kameda, André L Takatsu-Coleman, Jaime L S Cunha, Vanessa C Abílio.   

Abstract

A biphasic effect of morphine on locomotion has been extensively described. Nevertheless, the effects of this opioid on other behavioral parameters have been overlooked. The aim of the present study was to verify the effects of different doses of morphine on motor behaviors observed in an open-field. Adult female mice were injected with saline or morphine (10, 15 and 20 mg/kg, i.p.) and observed in an open-field for quantification of locomotor and rearing frequencies as well as duration of immobility and grooming. The lowest dose of morphine decreased locomotion (and increased immobility duration) while the highest dose increased it. All doses tested decreased rearing and grooming. Thus, the effects of morphine on locomotion do not parallel to its effects on rearing and grooming. Our results indicate that locomotion not always reflects the effect of drugs on motor activity, which can be better investigated when other behavioral parameters are concomitantly taken into account.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16083952     DOI: 10.1016/j.pbb.2005.07.004

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  22 in total

1.  LPS-induced sickness behavior is not affected by selenium but is switched off by psychogenic stress in rats.

Authors:  Túlio R R Mazuco; Thalles F Biondi; Ericka P Silva; Maria M Bernardi; Thiago Berti Kirsten
Journal:  Vet Res Commun       Date:  2019-11-23       Impact factor: 2.459

2.  Central effects of ethanol interact with endogenous mu-opioid activity to control isolation-induced analgesia in maternally separated infant rats.

Authors:  Michael E Nizhnikov; Andrey P Kozlov; Tatiana A Kramskaya; Elena I Varlinskaya; Norman E Spear
Journal:  Behav Brain Res       Date:  2013-12-04       Impact factor: 3.332

3.  Androgens and opiates: testosterone interaction with morphine self-administration in male rats.

Authors:  Sarah E Cooper; Ruth I Wood
Journal:  Neuroreport       Date:  2014-05-07       Impact factor: 1.837

4.  Thiamine deficiency and recovery: impact of recurrent episodes and beneficial effect of treatment with Trolox and dimethyl sulfoxide.

Authors:  Ketren Carvalho Gomes; Francisco Wanderson Bizerra Lima; Helen Quézia da Silva Aguiar; Suiane Silva de Araújo; Clarissa Amorim Silva de Cordova; Fabiano Mendes de Cordova
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2021-09-01       Impact factor: 3.195

5.  Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain.

Authors:  Nemat Khan; Andy Kuo; David A Brockman; Matthew A Cooper; Maree T Smith
Journal:  Inflammopharmacology       Date:  2017-09-30       Impact factor: 4.473

6.  Morphine-induced changes in acetylcholine release in the interpeduncular nucleus and relationship to changes in motor behavior in rats.

Authors:  Olga D Taraschenko; Heather Y Rubbinaccio; Joseph M Shulan; Stanley D Glick; Isabelle M Maisonneuve
Journal:  Neuropharmacology       Date:  2007-04-29       Impact factor: 5.250

7.  Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects.

Authors:  Ram Kandasamy; Todd M Hillhouse; Kathryn E Livingston; Kelsey E Kochan; Claire Meurice; Shainnel O Eans; Ming-Hua Li; Andrew D White; Bernard P Roques; Jay P McLaughlin; Susan L Ingram; Neil T Burford; Andrew Alt; John R Traynor
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-20       Impact factor: 11.205

8.  Inhibition of nociceptive responses after systemic administration of amidated kyotorphin.

Authors:  M M B Ribeiro; A Pinto; M Pinto; M Heras; I Martins; A Correia; E Bardaji; I Tavares; M Castanho
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

9.  Chronic methadone treatment and repeated withdrawal impair cognition and increase the expression of apoptosis-related proteins in mouse brain.

Authors:  Mónica Tramullas; Carmen Martínez-Cué; María A Hurlé
Journal:  Psychopharmacology (Berl)       Date:  2007-03-24       Impact factor: 4.415

10.  Effects of mu- and kappa-2 opioid receptor agonists on pain and rearing behaviors.

Authors:  John K Neubert; Heather L Rossi; Jonathan Pogar; Alan C Jenkins; Robert M Caudle
Journal:  Behav Brain Funct       Date:  2007-09-20       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.